| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Common Stock | Options Exercise | $0 | +3.58K | +18.88% | $0.00 | 22.5K | Mar 31, 2023 | Direct | |
| transaction | OGN | Common Stock | Tax liability | -$28.3K | -1.23K | -5.44% | $23.09 | 21.3K | Mar 31, 2023 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -3.58K | -33.33% | $0.00 | 7.16K | Mar 31, 2023 | Common Stock | 3.58K | Direct | F1, F2 | |
| transaction | OGN | Restricted Stock Units | Award | $0 | +19.7K | $0.00 | 19.7K | Mar 31, 2023 | Common Stock | 19.7K | Direct | F3, F4 | ||
| transaction | OGN | Stock Option (right to buy) | Award | $0 | +70.6K | $0.00 | 70.6K | Mar 31, 2023 | Common Stock | 70.6K | $23.52 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock. |
| F2 | On March 31, 2023, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2024 and March 31, 2025. |
| F3 | The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. |
| F4 | These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026. |
| F5 | The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026. |